Trials / Completed
CompletedNCT03004222
A Study to Determine the Effectiveness of Utilizing Intraperitoneal Bupivacaine
A Randomized Double Blinded Study to Determine the Effectiveness of Utilizing Intraperitoneal Bupivacaine: Does it Reduce Post-operative Opioid Use Following Laparoscopic Appendectomy?
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 137 (actual)
- Sponsor
- Metro Health, Michigan · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research is to determine if spraying a local anesthetic to the cecum after a laparoscopic appendectomy decreases the amount of narcotics (pain medicine) needed after surgery and reduces the time to discharge from the hospital.
Detailed description
The purpose of this study is to determine the effectiveness of using intraperitoneal anesthetic during appendectomy. Subjects will be randomized to receive either 20 mL 0.5% bupivicaine or 20 mL of normal saline (placebo) instilled in the right lower quadrant at the cecum after appendix has been removed. Narcotic consumption will be tracked postoperatively. Hypothesis is that instilling local anesthetic at the cecum during a laparoscopic appendectomy will decrease the amount of narcotic a patient uses postoperatively. Secondarily, this study will attempt to determine if there is a decrease in length of stay for the subjects randomized to the anesthetic infiltration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bupivacaine | 20 ml of 0.5% Bupivacaine |
| DRUG | Placebos |
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2017-11-01
- Completion
- 2017-11-01
- First posted
- 2016-12-28
- Last updated
- 2018-01-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03004222. Inclusion in this directory is not an endorsement.